Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 28,096 | 5,897 | 10,654 | 8,517 | 28,049 |
| Gross Profit | 28,096 | 5,897 | 10,654 | 8,517 | 28,049 |
| Operating Expenses | 47,475 | 45,029 | 45,690 | 43,191 | 37,854 |
| Operating Income | -19,379 | -39,132 | -35,036 | -34,674 | -9,805 |
| Interest Expense | 0 | 657 | 612 | 820 | 847 |
| Other Income | -4,133 | 679 | -2,477 | 4,592 | 4,500 |
| Pre-tax Income | -23,512 | -39,110 | -38,125 | -30,902 | -6,152 |
| Income Tax | 2,500 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -26,012 | -39,110 | -38,125 | -30,902 | -6,152 |
| Net Income | $-26,012 | $-39,110 | $-38,125 | $-30,902 | $-6,152 |
| EPS Basic Total Ops | -5.50 | -8.40 | -8.30 | -6.70 | -1.30 |
| EPS Basic Continuous Ops | -5.54 | -8.41 | -8.24 | -6.69 | -1.33 |
| EPS Diluted Total Ops | -5.50 | -8.40 | -8.30 | -6.70 | -1.30 |
| EPS Diluted Continuous Ops | -5.54 | -8.41 | -8.24 | -6.69 | -1.33 |
| EBITDA(a) | $-17,615 | $-37,259 | $-32,922 | $-32,768 | $-7,987 |